Product Program year 2025 Source: CMS Open Payments

VERITAS Vision System

Device Optics

PDI 05050474700864

Open in the dashboard

General payments

$342,292

3,107 payments

Research payments

$41,348

2 payments

Through program year 2025, $342,292 in general payments and $41,348 in research payments were reported against VERITAS Vision System (Optics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $71,100 925
2025 Research $41,348 2
2024 General $82,268 548
2023 General $60,539 548
2022 General $89,336 872
2021 General $39,049 214

Breakdown

Who paid General payments · program years 2021–2025
  1. Johnson & Johnson Surgical Vision, Inc. $340,654 3,088 payments
  2. Johnson & Johnson Vision Care, Inc. $1,487 17 payments
  3. Janssen Pharmaceuticals, Inc $151 2 payments
Top recipients General payments · program year 2025
  1. Andrew Schwartz Ophthalmology · New York, NY $10,992 15% · 4 payments
  2. Carlton Yuen Ophthalmology · Honolulu, HI $2,894 4% · 9 payments
  3. Sumit Garg Cornea and External Diseases Specialist · Irvine, CA $1,877 3% · 8 payments
  4. Ronald Rebenitsch Ophthalmology · Oklahoma City, OK $1,875 3% · 9 payments
  5. Surendra Basti Ophthalmology · Chicago, IL $1,728 2% · 8 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Ophthalmology $61,030 87% · 378 practitioners
  2. Cornea and External Diseases Specialist Ophthalmology $2,533 4% · 11 practitioners
  3. Optometrist $2,105 3% · 33 practitioners
  4. Ophthalmic Plastic and Reconstructive Surgery Ophthalmology $1,063 2% · 1 practitioner
  5. Glaucoma Specialist Ophthalmology $815 1% · 10 practitioners

The top 5 of 25 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $14,142 20% · 28 recipients
  2. California $7,921 11% · 53 recipients
  3. Florida $6,752 9% · 41 recipients
  4. Texas $6,291 9% · 66 recipients
  5. North Carolina $3,349 5% · 20 recipients

The top 5 of 40 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

3,107 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record